Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: New Constructs, LLC
$25.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Webmd Health Corp Raises Q2, FY 2013 Guidance


Friday, 12 Jul 2013 06:45am EDT 

Webmd Health Corp announced that for second quarter of 2013, it expects revenue to be between $124 million and $125 million. Prior financial guidance provided for revenue to be in excess of $115 million. Adjusted EBITDA to be approximately $29 million, or approximately 23% of revenue. Prior financial guidance provided for Adjusted EBITDA, as a percentage of revenue, to be in excess of 18%. Net income to be approximately $3 million, or $0.05 per diluted share, or approximately 2% of revenue. Prior financial guidance provided for net loss, as a percentage of revenue, to be approximately (1%). For fiscal 2013, it expects revenue of $485 million to $505 million. Prior financial guidance provided for revenue of $450 million to $470 million. Adjusted EBITDA of $100 million to $110 million. Prior financial guidance provided for adjusted EBITDA of $75 million to $88 million. Net income of $3 million to $11 million. Prior financial guidance provided for net loss of $(13) million to $(1.5) million. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $476 million, EBITDA of $89 million and EPS of $(0.02) for fiscal 2013; revenue of $117 million, EBITDA of $29 million and EPS of $0.00 for second quarter of 2013. 

Company Quote

50.38
0.44 +0.88%
11:24am EDT